Tecan Group AG (SWX:TECN)

Market Cap	1.85B
Revenue (ttm)	906.60M
Net Income (ttm)	63.13M
Shares Out	12.70M
EPS (ttm)	4.95
PE Ratio	29.45
Forward PE	20.14
Dividend	3.00 (2.06%)
Ex-Dividend Date	Apr 14, 2025

Volume	62,487
Average Volume	61,380
Open	144.70
Previous Close	145.80
Day's Range	143.50 - 150.40
52-Week Range	131.50 - 248.00
Beta	0.97
RSI	42.36
Earnings Date	Mar 16, 2026

About Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized O...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1980
• Employees: 3,341
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: TECN

Financial Performance

In 2024, Tecan Group AG's revenue was 934.28 million, a decrease of -13.04% compared to the previous year's 1.07 billion. Earnings were 67.66 million, a decrease of -48.77%.